Press Releases

Oct 14, 2020

Veracyte Announces Two Presentations to Be Shared at CHEST Annual Meeting 2020

Read More

Oct 07, 2020

Veracyte to Release Third Quarter 2020 Financial Results on November 2, 2020

Read More

Sep 24, 2020

Veracyte Receives ADLT Status for Envisia Genomic Classifier From Centers for Medicare and Medicaid Services

Read More

Sep 15, 2020

Veracyte to Present at Two Investor Conferences

Read More

Sep 14, 2020

Veracyte Announces Promotion of Richard T. Kloos, M.D. To Executive Medical Director

Read More

Sep 11, 2020

Veracyte Announces Initiation of Consensus Study Exploring Medical Utility of Multiple Breast Cancer Genomic Tests

Read More

Sep 04, 2020

Veracyte to Present at Upcoming Investor Conferences

Read More

Aug 24, 2020

Veracyte Named a San Francisco Bay Area “Top Workplace” for Seventh Consecutive Year

Read More

Aug 07, 2020

Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read More

Aug 05, 2020

Veracyte Announces New Real-World Data Reinforcing the Potential Clinical Value of Percepta and Envisia Classifiers to Improve Diagnosis of Serious Lung Diseases

Read More